Piper vs Gala vs PlexusDx (2026)

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Cross-shopping Piper (rebranding to Polly on April 29, 2026) against Gala GLP-1 leaves most readers with a clean question and a messy answer. Piper publishes its monthly, 3-month, and 6-month tiers ($179/$166/$135 per month for compounded semaglutide; $279/$216/$199 per month for compounded tirzepatide) and names Vials Rx as the compounding pharmacy partner inside its Help Center. Gala advertises a $179/mo headline that requires an annual commitment, sells compounded microdosing at $149/mo, and lists brand-name Ozempic at $1,299/mo — with a larger Trustpilot footprint (1,076 reviews at 4.4 stars) but no publicly named pharmacy partner. Both lead with compounded medications. Both have BBB F ratings. Neither runs a genetic baseline before titration. This article walks the actual cost math, the pharmacy-transparency gap, the cancellation rules, and where PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 Protocol sit relative to both — because the choice between Piper, Gala, and PlexusDx isn't really about which platform looks slicker. It's about pharmacy auditability, total annualized cost, and whether your dose is anchored to a measurable genetic baseline before week one.

Piper vs Gala GLP-1 vs PlexusDx — quick decision frame

Three pricing models cover this slice of the cash-pay GLP-1 market. Piper (→ Polly) is a tiered all-inclusive compounded platform: $135–$179/mo for compounded semaglutide and $199–$279/mo for compounded tirzepatide, depending on commitment length, with the same dose included at every tier. Gala GLP-1 is a similar all-inclusive compounded model with a wider menu ($199/mo standard semaglutide, $179/mo on annual; $179–$199/mo tirzepatide; $149/mo microdose; $1,299/mo brand-name Ozempic) and no publicly named pharmacy partner. PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide from licensed U.S. compounding pharmacies — Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, and GLP-Squared dual-compound therapy at $249/mo — paired with the optional Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) so dosing decisions are anchored to the patient's GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants rather than a population-average titration schedule. All three models are cash-pay; PlexusDx adds no membership fee and operates in all 50 states (five require a scheduled live consultation rather than async intake).

The real annual cost: Piper vs Gala vs PlexusDx

Sticker prices on landing pages are misleading because commitment length, plan tier, and dose-included rules differ across providers. For a cash-pay patient choosing compounded semaglutide, Piper's annual total runs $1,620/year on the 6-month plan ($135 × 12), $1,992/year on the 3-month plan ($166 × 12), or $2,148/year true month-to-month ($179 × 12). Gala's compounded semaglutide is $2,148/year on the annual subscription ($179 × 12) or roughly $2,388/year on the standard $199/mo plan. For compounded tirzepatide, Piper runs $2,388/year on the 6-month plan, $2,592/year on the 3-month plan, and $3,348/year month-to-month; Gala lands at $2,148/year on annual and $2,388/year on the 3-month plan. PlexusDx Weight Management Protocols range from $1,548/year on the Microdose GLP-1 Protocol ($129/mo flat) to $2,148–$2,748/year on Semaglutide Injection, $2,748–$3,708/year on Tirzepatide Injection, and $2,148–$3,900/year on GLP-Squared. Add $99 for the Precision Peptide Genetic Test as an add-on after month one and the genetics-included totals stay competitive on the entry-tier protocols. The headline takeaway: Piper's 6-month tier is the cheapest compounded semaglutide in this comparison; PlexusDx's Microdose GLP-1 Protocol is the cheapest GLP-1 entry point overall at $129/mo flat with no commitment ladder.

Pharmacy transparency: Vials Rx, “nationwide network,” and licensed U.S. pharmacies

This is the substantive auditability difference and it matters more than most landing pages let on. Piper publicly identifies Vials Rx as its compounding pharmacy partner in its Help Center — a licensed U.S.-based 503A pharmacy that prepares prescriptions for individual patients. A consumer can confirm the partner before paying. Gala describes a “wide network of pharmacies across all 50 states” without naming a specific partner publicly; the dispensing pharmacy is typically disclosed on the shipping label after the order ships. PlexusDx Weight Management Protocols are filled by licensed U.S. compounding pharmacies as part of an all-inclusive protocol that includes the async (or live, in five states) clinician visit, prescription, compounded medication, and shipping in one bill. None of the three sells FDA-approved finished products like Wegovy, Zepbound, Ozempic, or Mounjaro — all three lead with compounded preparations of the same active ingredients (semaglutide and tirzepatide), which are not FDA-approved finished drug products. Gala does offer brand-name Ozempic separately at $1,299/mo for cash-pay. The compounded vs branded distinction is about FDA approval status of the finished product, not the active ingredient itself.

Cancellation rules, refund windows, and what locks you in

The three platforms handle cancellation differently and the differences cost real money if you don't read the fine print. Piper allows cancellation with a full refund before the medical intake form is submitted; once intake is submitted and clinical review begins, current-order cancellations and refunds are typically not possible. Multi-month plans (3 or 6 months) at Piper are prepaid and not refundable after the first month — the tradeoff for the lower per-month rate. Gala lets you cancel at any time but requires notice at least 72 hours before your next billing date; refunds are generally not provided except for medical disqualification. PlexusDx Weight Management Protocols are billed monthly with no membership fee and no multi-month prepay lock-in — a patient can stop the protocol after any month without forfeiting prepaid future months, and the Precision Peptide Genetic Test is a one-time $298 charge (or $99 add-on) rather than a recurring fee. If you're choosing primarily on cancellation flexibility, Gala's anytime-with-72-hours-notice rule is the simplest, PlexusDx's monthly billing avoids prepay forfeiture, and Piper's lowest per-month rates require you to commit 6 months upfront.

Trust signals: Trustpilot, BBB, and safety

Public review data tells different stories at different sample sizes. As of April 22, 2026 Gala carries 1,076 Trustpilot reviews averaging 4.4 stars, an iOS/Android tracker app, and an F rating with 10 unanswered complaints at the BBB. Piper carries 197 Trustpilot reviews averaging 3.1 stars, an F rating with 5 complaints at the BBB, and a Help Center where pricing and pharmacy partner are auditable before checkout. PlexusDx focuses on protocol-plus-genetics rather than scaling a single compounded SKU. None of these platforms is risk-free — the boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, and GLP-1 medications carry well-documented GI side effects (nausea, vomiting, diarrhea, constipation) plus less-common documented events including pancreatitis, gallbladder disease, and acute kidney injury.

Why a genetic baseline changes the conversation

GLP-1 response varies meaningfully across patients. Variants in GLP1R (the GLP-1 receptor itself), GIPR (GIP receptor — particularly rs1800437, the headline variant for differential GLP-1 response), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide. The Precision Peptide Genetic Test maps 48 unique genes and 57 variants across 14 health pathways, returning 150+ genetic insights including 34 weight-management insights through the Peptide Pathways Report in the PlexusDx Results Portal. The prescribing clinician can use that baseline to decide whether a faster-than-typical titration, a slower one, or a tirzepatide-first approach is more likely to fit your biology before the first injection. Neither Piper nor Gala performs this stratification — both start from a population-average titration schedule and adjust based on subjective tolerability over the first 8–12 weeks. PlexusDx anchors that same conversation to a measurable genetic baseline, available standalone for $298 or as a $99 add-on after your first month on any protocol such as Semaglutide Injection, Tirzepatide Injection, or the Microdose GLP-1 Protocol.

Which one fits — a four-question frame

Question 1: Are you cost-driven and willing to commit 6 months upfront for the lowest compounded semaglutide rate? Piper's 6-month plan at $135/mo is the lowest in this comparison — but only if you're confident you'll tolerate the medication for the full window. Question 2: Do you want a wider menu including microdosing and brand-name Ozempic on the same platform? Gala covers more SKUs and has the larger consumer footprint, though pharmacy partner is not publicly named. Question 3: Do you want a true month-to-month entry point at the lowest possible total cost, with no prepay lock-in and the option to add a genetic baseline? PlexusDx Microdose GLP-1 Protocol is $129/mo flat, no commitment ladder, with the Precision Peptide Genetic Test available as a $99 add-on after month one. Question 4: Do you want a genetic baseline informing dose and titration before the first injection? PlexusDx is the only option in this comparison that includes the Precision Peptide Genetic Test. If branded Wegovy or Zepbound is your priority, none of the three is the right tool — you need an insurance-covered prescription or Lilly Direct's $499/mo Zepbound self-pay vials.

Frequently asked questions

Which is cheaper, Piper or Gala?

Piper is cheaper on compounded semaglutide ($135/mo on a 6-month plan vs Gala's $199/mo standard plan, though Gala advertises a $179/mo annual rate). Gala is slightly cheaper on compounded tirzepatide over a full year on the annual plan ($2,148/year vs Piper's $2,388/year on the 6-month plan). PlexusDx Microdose GLP-1 Protocol is the cheapest GLP-1 entry point overall at $129/mo flat with no commitment ladder.

Are Piper and Gala FDA-approved?

The main products both providers sell are not FDA-approved. Both prescribe compounded semaglutide and tirzepatide prepared by state-licensed compounding pharmacies. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality as finished products. Gala does also offer brand-name Ozempic at $1,299/mo, which is FDA-approved. PlexusDx Weight Management Protocols are also compounded; only the branded GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro) are FDA-approved finished drugs.

Does Piper use a real pharmacy?

Yes. Piper's Help Center identifies Vials Rx as its compounding pharmacy partner — a licensed U.S.-based 503A pharmacy that prepares prescriptions for individual patients.

Does Gala name its pharmacy partners?

Not publicly on the main marketing pages. Gala describes a nationwide pharmacy network across 50 states; the specific pharmacy filling your prescription is typically disclosed on the shipping label rather than before checkout.

Can you cancel Piper or Gala?

Piper allows full-refund cancellation before medical intake is submitted; after intake and shipping, refunds are typically not available, and multi-month plans are prepaid and non-refundable after the first month. Gala lets you cancel anytime but requires at least 72 hours' notice before the next billing date, with refunds generally limited to medical disqualification.

How does PlexusDx compare on price and personalization?

PlexusDx Microdose GLP-1 Protocol starts at $129/mo flat, Semaglutide Injection runs $149/mo, and Tirzepatide Injection runs $249/mo — all monthly billing, no prepay lock-in, no membership. The Precision Peptide Genetic Test is $298 standalone or $99 as an add-on after month one and is the only genetic baseline offered by any provider in this three-way comparison.

Do Piper, Gala, or PlexusDx accept insurance?

All three operate on a cash-pay basis. Piper notes HSA/FSA reimbursement may be available depending on your plan. PlexusDx is cash-pay with no membership fee and no insurance billing. If insurance-covered branded GLP-1 (Wegovy or Zepbound at low copay) is your priority, you need a different route entirely — none of these three platforms is the right tool for that job.

Piper vs Gala GLP-1 vs PlexusDx (2026): Pricing, Pharmacy, and Genetic Personalization | PlexusDx